1. Home
  2. AUPH vs NBXG Comparison

AUPH vs NBXG Comparison

Compare AUPH & NBXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • NBXG
  • Stock Information
  • Founded
  • AUPH 1993
  • NBXG 2021
  • Country
  • AUPH Canada
  • NBXG United States
  • Employees
  • AUPH N/A
  • NBXG N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • NBXG Trusts Except Educational Religious and Charitable
  • Sector
  • AUPH Health Care
  • NBXG Finance
  • Exchange
  • AUPH Nasdaq
  • NBXG Nasdaq
  • Market Cap
  • AUPH 1.3B
  • NBXG 1.0B
  • IPO Year
  • AUPH 1999
  • NBXG N/A
  • Fundamental
  • Price
  • AUPH $9.50
  • NBXG $13.19
  • Analyst Decision
  • AUPH Strong Buy
  • NBXG
  • Analyst Count
  • AUPH 3
  • NBXG 0
  • Target Price
  • AUPH $10.33
  • NBXG N/A
  • AVG Volume (30 Days)
  • AUPH 1.5M
  • NBXG 243.7K
  • Earning Date
  • AUPH 11-07-2024
  • NBXG 01-01-0001
  • Dividend Yield
  • AUPH N/A
  • NBXG 10.25%
  • EPS Growth
  • AUPH N/A
  • NBXG N/A
  • EPS
  • AUPH N/A
  • NBXG N/A
  • Revenue
  • AUPH $220,361,000.00
  • NBXG N/A
  • Revenue This Year
  • AUPH $36.97
  • NBXG N/A
  • Revenue Next Year
  • AUPH $16.43
  • NBXG N/A
  • P/E Ratio
  • AUPH N/A
  • NBXG N/A
  • Revenue Growth
  • AUPH 38.72
  • NBXG N/A
  • 52 Week Low
  • AUPH $4.71
  • NBXG $9.31
  • 52 Week High
  • AUPH $10.67
  • NBXG $12.23
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 58.10
  • NBXG 50.24
  • Support Level
  • AUPH $9.22
  • NBXG $13.05
  • Resistance Level
  • AUPH $9.76
  • NBXG $13.35
  • Average True Range (ATR)
  • AUPH 0.42
  • NBXG 0.18
  • MACD
  • AUPH -0.02
  • NBXG -0.03
  • Stochastic Oscillator
  • AUPH 36.73
  • NBXG 23.36

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.

About NBXG Neuberger Berman Next Generation Connectivity Fund Inc.

Neuberger Berman Next Generation Connectivity Fund Inc. is a non-diversified, closed-end management investment company. The fund's investment objectives are to provide capital appreciation and income.

Share on Social Networks: